Batiancila, Aime .

HRN: 07-51-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
MUPIROCIN 2%, 15G (TUBE)
01/31/2026
02/07/2026
APPLY TO POST OP SITE
2%
OD
S/P Primary Classical Cs
Remove - Pending Acceptance
02/01/2026
CEFUROXIME 500MG (TAB)
02/01/2026
02/07/2026
ORAL
500mg
2 Times A Day
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: